EXAS vs FSS · rev $2.76B vs P/E 32, rev $1.30B
EXACT Sciences Corporation (EXAS) versus Federal Signal Corporation (FSS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Federal Signal Corporation (FSS) is a pollution & treatment controls company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FSS revenue for 2026-06-30 was $1.30B. Net income was $156.5M. FSS currently screens at market cap $6.71B and trailing P/E 32.3.
EXAS currently screens at market cap $20.03B. FSS currently screens at market cap $6.71B and trailing P/E 32.3.
Not investment advice. Open the EXAS and FSS stock pages for the full models.
Not investment advice.